Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fuentes

Showing results (211-220 of 237) with videos related to

Pageof 24
Sort By:
JACC. Clinical Electrophysiology|May 11, 2023
Acute and Long-Term Scar Characterization of Venous Ethanol Ablation in the Left Ventricular SummitStephanie C Fuentes Rojas, Maan Malahfji, Liliana Tavares, et al.
The Journal of Clinical Endocrinology and Metabolism|November 28, 2020
Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate CancerJuan M Jiménez-Vacas, Vicente Herrero-Aguayo, Antonio J Montero-Hidalgo, et al.
Brain : a Journal of Neurology|November 3, 2020
Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3Antonio C Fuentes-Fayos, Mari C Vázquez-Borrego, Juan M Jiménez-Vacas, et al.
European Journal of Cancer Care|August 2, 2016
Body weight changes after adjuvant chemotherapy of patients with breast cancer: results of a Mexican cohort studyA Vargas-Meza, M Chavez-Tostado, A O Cortes-Flores, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2024
Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA studyS Lu, M-J Ahn, T Reungwetwattana, et al.
Actas Urologicas Espanolas|July 9, 2025
Clinical profile and risk factors identified in patients with renal cancer in Mexican populationG Sánchez-Villaseñor, E A Pérez-Du Pond, I Jasso-García, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 11, 2022
Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genesJuan M Jiménez-Vacas, Antonio J Montero-Hidalgo, Enrique Gómez-Gómez, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenariosHeberto Aquino Bruno, Ole De Backer, Gilbert H L Tang, et al.
NAR Cancer|December 15, 2022
A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1Adria Closa, Marina Reixachs-Solé, Antonio C Fuentes-Fayos, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 26, 2022
Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumorsSergio Pedraza-Arevalo, Emilia Alors-Pérez, Ricardo Blázquez-Encinas, et al.
Pageof 24

Showing results (211-220 of 237) with videos related to

Sort By:
Pageof 24
JACC. Clinical Electrophysiology|May 11, 2023
Acute and Long-Term Scar Characterization of Venous Ethanol Ablation in the Left Ventricular SummitStephanie C Fuentes Rojas, Maan Malahfji, Liliana Tavares, et al.
The Journal of Clinical Endocrinology and Metabolism|November 28, 2020
Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate CancerJuan M Jiménez-Vacas, Vicente Herrero-Aguayo, Antonio J Montero-Hidalgo, et al.
Brain : a Journal of Neurology|November 3, 2020
Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3Antonio C Fuentes-Fayos, Mari C Vázquez-Borrego, Juan M Jiménez-Vacas, et al.
European Journal of Cancer Care|August 2, 2016
Body weight changes after adjuvant chemotherapy of patients with breast cancer: results of a Mexican cohort studyA Vargas-Meza, M Chavez-Tostado, A O Cortes-Flores, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2024
Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA studyS Lu, M-J Ahn, T Reungwetwattana, et al.
Actas Urologicas Espanolas|July 9, 2025
Clinical profile and risk factors identified in patients with renal cancer in Mexican populationG Sánchez-Villaseñor, E A Pérez-Du Pond, I Jasso-García, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 11, 2022
Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genesJuan M Jiménez-Vacas, Antonio J Montero-Hidalgo, Enrique Gómez-Gómez, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenariosHeberto Aquino Bruno, Ole De Backer, Gilbert H L Tang, et al.
NAR Cancer|December 15, 2022
A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1Adria Closa, Marina Reixachs-Solé, Antonio C Fuentes-Fayos, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 26, 2022
Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumorsSergio Pedraza-Arevalo, Emilia Alors-Pérez, Ricardo Blázquez-Encinas, et al.
Pageof 24